Results 171 to 180 of about 36,647 (208)
Some of the next articles are maybe not open access.

Lung infection with nontuberculous mycobacteria

Radiología (English Edition), 2023
To describe the epidemiology and CT findings for nontuberculous mycobacterial lung infections and outcomes depending on the treatment.We retrospectively studied 131 consecutive patients with positive cultures for nontuberculous mycobacteria between 2005 and 2016. We selected those who met the criteria for nontuberculous mycobacterial lung infection. We
C, Cano Rodríguez   +6 more
openaire   +2 more sources

Clinical Manifestations of Nontuberculous Mycobacteria

2006
Tuberculosis and leprosy have been widely recognized for over 2000 years and their causative organisms were identifi ed in the nineteenth century when microscopy fi rst became available. In contrast, nontuberculous mycobacteria (NTM), also known as atypical mycobacteria or mycobacteria other than Mycobacterium tuberculosis (MOTT), were not widely ...
Heyderman, Robert S, Clark, Julia
openaire   +6 more sources

Nontuberculous mycobacteria in the environment

Clinics in Chest Medicine, 2002
It is likely that the incidence of infection by environmental opportunistic mycobacteria will continue to rise. Part of the rise will be caused by the increased awareness of these microbes as human pathogens and improvements in methods of detection and culture.
openaire   +3 more sources

Nontuberculous mycobacteria in cystic fibrosis

Current Opinion in Pulmonary Medicine, 2021
Purpose of review Nontuberculous mycobacteria (NTM) are challenging infections among people with cystic fibrosis (pwCF) as the source, modes of transmission, and best practices for diagnosis and treatment are not known. Investigators have defined aspects of NTM infection that are unique to the CF population, as well as features
Jerry A, Nick   +3 more
openaire   +2 more sources

Treatment of Other Nontuberculous Mycobacteria

Seminars in Respiratory and Critical Care Medicine, 2018
AbstractNontuberculous mycobacteria (NTM) are numerous, and for the vast majority of them, randomized studies are lacking and data regarding optimal treatment are limited. When Mycobacterium avium complex (MAC) and M. abscessus are excluded, the main NTM are M. xenopi, M. kansasii, M. malmoense, M. szulgai, and M. simiae. Treatment is long (at least 12
Damien, Basille   +2 more
openaire   +2 more sources

Laboratory diagnosis of nontuberculous mycobacteria

Clinics in Chest Medicine, 2002
In conclusion, it is important to realize that there is no "stand alone" assay for the identification of NTM. Many new species may not be recognized in all assays. Newer molecular tests are more accurate for identification than phenotypic tests and have significantly improved turnaround time.
Akos, Somoskovi   +4 more
openaire   +2 more sources

Nontuberculous mycobacteria in cystic fibrosis

Infectious Disease Clinics of North America, 2002
The incidence of NTM pulmonary infections increasingly is recognized in patients with CF. This may reflect the increasing longevity of this population with increased environmental exposure time, a high index of suspicion, and/or some as of yet unidentified predisposing factor(s). The most common species of NTM in CF is MAC, followed by M.
Deborah L, Ebert, Kenneth N, Olivier
openaire   +2 more sources

Pathogenesis of nontuberculous mycobacteria infections

Clinics in Chest Medicine, 2002
M avium is a microorganism well adapted to living in the environment and in different hosts. During the past 15 years, a substantial amount of information has been accumulated about the mechanisms used by M avium to cross the host's mucosal barrier, replicate inside cells, circumvent the host's immune response, and persist inside the host. It turns out
Jeffery, McGarvey, Luiz E, Bermudez
openaire   +2 more sources

Nontuberculous mycobacteria.

American family physician, 1984
Nontuberculous mycobacteria are identified in almost half of the cultures reported positive for mycobacteria in clinical laboratories in the United States. While many represent saprophytic colonization or laboratory contamination, a significant number of these organisms are the agents of disease.
C B, Hartley, H, Yeager
openaire   +1 more source

Nontuberculous Mycobacteria

Clinics in Chest Medicine, 2022
Emilyn Costa Conceição   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy